Molecular Cancer Research Impact Factor, Indexing, Ranking

Molecular Cancer Research Impact Factor, Indexing, Ranking

Molecular Cancer Research (MCR) is a scholarly journal dedicated to publishing research in the field of Medicine. American Association for Cancer Research is the publisher of this esteemed journal. The P-ISSN assigned to Molecular Cancer Research is 1541-7786 and its abbreviated form is Mol Cancer Res.


Aim and Scope

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.


Journal Details

Journal title Molecular Cancer Research (MCR)
Abbreviation Mol Cancer Res
Print ISSN 1541-7786
Online ISSN 1557-3125
Publisher Name American Association for Cancer Research
Editor-in-chief Massimo Loda
Subject Category Medicine

Abbreviation

Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Molecular Cancer Research Journal is Mol Cancer Res.


Ranking

The Ranking of the Journal in 2024 is 1778. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.


Impact Factor

The Journal's Impact Factor in 2024 is 5.2. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors


SCImago

The Journal SCImago in 2024 is 1.668. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.


H-Index

The Journal's H-Index in 2024 is 148. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.


Quartile

The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.


Journal's Indexing

The Journal is indexed in (Indexing details)

PubMed Scopus Web of Science UGC Embase DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.


Journal's Metrics for 2024

Abbreviation Mol Cancer Res
Access type Hybrid
Impact Factor 5.2
SJR 1.668
SNIP 1.012
Ranking 1778
CiteScore 10.6
H-Index 148

Editorial Board

The Editor-in-chief of the Journal is Massimo Loda


Submission/Processing Fee (APC)

Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of the Journal is Publication fee: $1900, APC for Open Access $6000


Call for paper

Call for paper : The Journal invites original research contributions for consideration of publication in Molecular Cancer Research journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.


How to publish in Molecular Cancer Research

Publishing in Molecular Cancer Research involves the following steps:

  • Research: Conduct high-quality, impactful research in the field of Medicine.
  • Familiarize Yourself: Read and understand the aims and scope of Molecular Cancer Research to ensure your work aligns with their focus.
  • Manuscript Preparation: Prepare your manuscript according to the Molecular Cancer Research guidelines, including formatting, length, and referencing style.
  • Submission: Submit your manuscript through the journal's online submission system.

Molecular Cancer Research FAQ

is journal indexed in PubMed?

Yes, the journal is indexed in PubMed.

is journal indexed in Scopus?

Yes, the journal is indexed in Scopus.

is journal indexed in UGC?

Yes, the journal is indexed in UGC.

is journal indexed in Index Copernicus?

No, the journal is not indexed in Index copernicus.

is a predatory journal?

No, journal is not a predatory journal.

What is the Imptact Factor of Molecular Cancer Research?

The Impact Factor of the Journal is 5.2.

What is the Ranking of the Journal?

The Ranking of the Journal is 1778.

is journal peer reviewed?

Yes the journal is a peer-reviewed journal.

is Molecular Cancer Research a good journal?

Yes the journal is a peer-reviewed journal and good to publish your paper.

What is Molecular Cancer Research?

Molecular Cancer Research (MCR) is a scholarly journal dedicated to publishing research in the field of Medicine. American Association for Cancer Research is the publisher of this esteemed journal.

is Molecular Cancer Research open access?

Yes, Molecular Cancer Research is a open access (Hybrid) journal.


Table of Contents

Who we are? Clarification: Journals Insights - Your Open Access Ally
Search For Journals, Indexing, Impact Factor etc.